MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 14, 2004; DOI: 10.1124/mol.104.004523


0026-895X/05/6703-883-890$20.00
Mol Pharmacol 67:883-890, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.004523v1
67/3/883    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bartsch, M.
Right arrow Articles by Kamps, J. A. A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bartsch, M.
Right arrow Articles by Kamps, J. A. A. M.
ORIGINAL ARTICLE

Optimized Targeting of Polyethylene Glycol-Stabilized Anti-Intercellular Adhesion Molecule 1 Oligonucleotide/Lipid Particles to Liver Sinusoidal Endothelial Cells

Martin Bartsch, Alida H. Weeke-Klimp, Henriëtte W. M. Morselt, Andrea Kimpfler, Sigridur A. Ásgeirsdóttir, Rolf Schubert, Dirk K. F. Meijer, Gerrit L. Scherphof, and Jan A. A. M. Kamps

Groningen University Institute for Drug Exploration (GUIDE), Department of Cell Biology (M.B., A.H.W.-K., H.W.M.M., G.L.S., J.A.A.M.K.), Pathology and Laboratory Medicine/Medical Biology (H.W.M.M., S.A.A., J.A.A.M.K.), Pharmacokinetics and Drug Delivery (D.K.F.M.), University of Groningen, The Netherlands; and the Department of Pharmaceutical Technology, University of Freiburg, Germany (A.K., R.S.).

Abstract

We prepared polyethylene glycol (PEG)-stabilized antisense oligonucleotide (ODN)/lipid particles from a lipid mixture including the positively charged amphiphile 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) and anti-intercellular adhesion molecule 1 (ICAM-1) antisense ODN by an extrusion method in the presence of 40% ethanol. These particles were targeted to scavenger receptors on liver endothelial cells by means of covalently coupled polyanionized albumin. Two types of such targeted particles were prepared, one with the albumin coupled to a maleimide group attached to the particle's lipid bilayer and the other with the protein coupled to a maleimide group attached at the distal end of added bilayer-anchored PEG chains. Upon intravenous injection, the ODN particles with bilayer-coupled albumin were cleared from the blood circulation at the same low rate as untargeted particles (<5% in 30 min). By contrast, the distal-end coupled particles were very rapidly cleared from the blood and preferentially taken up by the endothelial cells of the hepatic sinusoid (55% of injected dose after 30 min). Despite this substantial endothelial targeting, no consistent inhibition of ICAM-1 expression could be demonstrated in this cell type, either in vivo or in vitro. However, in J774 cells that also express scavenger receptors and ICAM-1, significant down-regulation of ICAM-1 mRNA was achieved with distal-end targeted lipid particles, as determined with real-time RT-PCR. It is concluded that massive delivery of ODN to cell types that express scavenger receptors can be achieved if lipid particles are provided with negatively charged albumin distally attached to bilayer anchored PEG chains.


Received July 2, 2004; accepted December 10, 2004

Address correspondence to: Jan A. A. M. Kamps, University of Groningen, Department Pathology and Laboratory Medicine/Medical Biology Section - Endothelial Cell Research and Vascular Drug Targeting, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. E-mail: j.a.a.m.kamps{at}med.rug.nl







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics